Eidos therapeutics, inc. (EIDX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Sep'17Jun'17
License revenue

-

-

26,691

-

-

-

-

-

-

-

-

Operating costs and expenses:
Cost of license revenue

-

-

2,500

-

-

-

-

-

-

-

-

Research and development (includes related party expense (benefit) of $(242) and $94 for the three months ended March 31, 2020 and 2019, respectively)

17,575

13,858

11,987

12,497

8,549

8,323

8,369

6,195

5,652

2,283

1,261

General and administrative (includes related party expense of $285 and $79 for the three months ended March 31, 2020 and 2019, respectively)

5,311

5,466

5,953

2,297

4,035

2,382

2,619

1,894

2,345

490

454

Total operating expenses

22,886

19,324

20,440

14,794

12,584

10,705

10,988

8,089

7,997

2,773

1,715

Loss from operations

-22,886

-19,324

6,251

-14,794

-12,584

-10,705

-10,988

-8,089

-7,997

-2,773

-1,715

Interest expense

518

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

580

671

680

741

851

1,862

374

-3,292

-879

-

-

Net and comprehensive loss

-22,824

-18,980

6,931

-14,053

-11,733

-9,854

-10,614

-11,381

-8,876

-2,773

-1,715

Deemed dividend related to redemption feature embedded in Convertible Promissory Notes payable to stockholders

-

-

-

-

-

0

0

0

6,523

-

-

Gain on extinguishment of Convertible Promissory Notes payable to stockholders

-

-

-

-

-

0

0

0

7,436

-

-

Net income (loss) attributable to common stock for basic and diluted net income (loss) per share

-

-

6,931

-

-

-

-10,614

-

-

-

-

Net income (loss) per share attributable to common stockholders, basic

-

-

0.19

-

-

-

-0.30

-

-

-

-

Net income (loss) per share attributable to common stockholders, diluted

-

-

0.18

-

-

-

-0.30

-

-

-

-

Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic

-

-

36,581

-

-

-

35,965

-

-

-

-

Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted

-

-

37,710

-

-

-

35,965

-

-

-

-

Net loss attributable to common stockholders

-

-

-

-14,053

-

-

-

-11,381

-7,963

-

-

Net loss per share - basic and diluted

-0.60

-

-

-0.39

-0.32

-

-

-1.40

-1.81

-0.74

-0.49

Weighted-average shares used in computing net loss per share - basic and diluted

38,009

-

-

36,309

36,175

-

-

8,109

4,392

3,752

3,514